| RS886041667 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS886041668 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile epilepsy syndrome, Early-infantile DEE |
| RS886041669 |
POGZ
|
Health Risk |
Pathogenic |
See cases, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS886041670 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 13 |
| RS886041671 |
AUTS2
|
Health Risk |
Pathogenic |
— |
| RS886041672 |
TCOF1
|
Health Risk |
Pathogenic |
— |
| RS886041673 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS886041674 |
CPAP
|
Health Risk |
Pathogenic |
— |
| RS886041675 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS886041676 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS886041677 |
NBEAL2
|
Health Risk |
Pathogenic |
— |
| RS886041678 |
VPS13B
|
Health Risk |
Pathogenic |
— |
| RS886041679 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS886041680 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041681 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041682 |
KMT2C
|
Health Risk |
Pathogenic |
— |
| RS886041683 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041684 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS886041685 |
SATB2
|
Health Risk |
Pathogenic |
— |
| RS886041686 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Congenital myopathy with fiber type disproportion |
| RS886041687 |
PIGG
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS886041688 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS886041690 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS886041691 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Malignant migrating partial seizures of infancy, Developmental and epileptic encephalopathy |
| RS886041692 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS886041693 |
WDR45
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation 5, Neurodegeneration with brain iron accumulation 5 |
| RS886041694 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041695 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886041696 |
SOS1
|
Health Risk |
Likely pathogenic |
Male infertility with azoospermia or oligozoospermia due to single gene mutation, Male infertility with azoospermia or oligozoospermia due to single gene mutation |
| RS886041697 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS886041698 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS886041699 |
EXT1
|
Health Risk |
Pathogenic |
— |
| RS886041700 |
ATRX
|
Health Risk |
Pathogenic |
— |
| RS886041701 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS886041703 |
MPLKIP
|
Health Risk |
Pathogenic |
— |
| RS886041704 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS886041705 |
DDX3X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 102 |
| RS886041706 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome 1, Inborn genetic diseases |
| RS886041707 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS886041708 |
GCH1
|
Health Risk |
Pathogenic |
— |
| RS886041709 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS886041710 |
FLNA
|
Health Risk |
Pathogenic |
Periventricular nodular heterotopia, Periventricular nodular heterotopia |
| RS886041712 |
CNKSR2
|
Health Risk |
Pathogenic |
— |
| RS886041713 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS886041714 |
COL4A1
|
Health Risk |
Pathogenic |
— |
| RS886041715 |
GNAO1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS886041716 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS886041717 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS886041719 |
TBX18
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886041720 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS886041721 |
ASPM
|
Health Risk |
Pathogenic |
— |
| RS886041722 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS886041723 |
HPS5
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome |
| RS886041724 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886041725 |
BCOR
|
Health Risk |
Pathogenic |
— |
| RS886041726 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041727 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886041729 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886041730 |
NR2F2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS886041731 |
KAT6A
|
Health Risk |
Pathogenic |
— |
| RS886041732 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS886041733 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886041734 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886041735 |
PRRT2
|
Health Risk |
Pathogenic |
— |
| RS886041736 |
DCX
|
Health Risk |
Pathogenic |
— |
| RS886041737 |
OFD1
|
Health Risk |
Pathogenic |
— |
| RS886041738 |
NR2F1
|
Health Risk |
Likely pathogenic |
Bosch-Boonstra-Schaaf optic atrophy syndrome, See cases |
| RS886041739 |
EP300
|
Health Risk |
Pathogenic |
— |
| RS886041740 |
RASA1
|
Health Risk |
Pathogenic |
— |
| RS886041741 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS886041742 |
RBM10
|
Health Risk |
Pathogenic |
— |
| RS886041743 |
KCNB1
|
Health Risk |
Pathogenic |
KCNB1-related disorder, KCNB1-related disorder |
| RS886041744 |
FOXG1
|
Health Risk |
Pathogenic |
FOXG1 disorder, FOXG1 disorder |
| RS886041745 |
RAG1
|
Health Risk |
Pathogenic |
— |
| RS886041746 |
MEN1
|
Health Risk |
Pathogenic |
— |
| RS886041747 |
CD40LG
|
Health Risk |
Pathogenic |
— |
| RS886041748 |
ATP2A2
|
Health Risk |
Pathogenic |
— |
| RS886041749 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS886041750 |
SERAC1
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS886041751 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS886041752 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS886041753 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS886041754 |
PURA
|
Health Risk |
Pathogenic |
PURA Syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS886041755 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS886041756 |
ACTG1
|
Health Risk |
Likely pathogenic |
— |
| RS886041757 |
CPLANE1
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS886041758 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS886041759 |
CYP11A1
|
Health Risk |
Pathogenic |
— |
| RS886041760 |
ANKRD11
|
Health Risk |
Pathogenic |
— |
| RS886041761 |
KCNA2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS886041762 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041763 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041764 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS886041765 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS886041766 |
GNAO1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS886041767 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS886041768 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886041769 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS886041771 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS886041772 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 1 |